Literature DB >> 24808983

A summary of a cochrane review: green and black tea for the primary prevention of cardiovascular disease.

Nancy Santesso1, Eric Manheimer2.   

Abstract

Entities:  

Year:  2014        PMID: 24808983      PMCID: PMC4010958          DOI: 10.7453/gahmj.2014.003

Source DB:  PubMed          Journal:  Glob Adv Health Med        ISSN: 2164-9561


× No keyword cloud information.

INTRODUCTION

Review authors in the Cochrane Collaboration conducted a review of the effects of green and black tea to prevent cardiovascular disease (CVD), such as heart attack and stroke. After searching for all relevant studies, they found 11 studies in 821 people who were healthy or at high risk of CVD. The findings of the review are summarised below.

TEA AND CARDIOVASCULAR DISEASE

CVD refers to many diseases that affect the heart and blood vessels. CVD includes cerebrovascular disease (such as stroke); peripheral arterial disease, in which arteries become blocked with plaque; and coronary heart disease, which can lead to a heart attack. Because CVD causes almost 30% of deaths around the world, there is research into ways to prevent and lower the risk of CVD. Preventing CVD can involve ways to lower blood pressure, lower triglyceride levels, lower total cholesterol levels, and lower the “bad” cholesterol (LDL) but raise the “good” cholesterol (HDL). Researchers have been testing whether certain foods or drinks could help prevent CVD. Tea has been used as medicine in many countries, and different types of tea have become popular. The two most popular types of tea are black and green. These teas are produced from the same leaves but using different methods. This means they contain different vitamins and minerals and different amounts of flavanols (a type of flavanoid) and caffeine. The question is, could drinking tea or taking tea extract prevent CVD? Summary of Findings Details about the quality of the evidence: Evidence was moderate quality due to the risk of bias in studies because there may not have been random sequence generation or allocation concealment. Evidence was low quality due to risk of bias and the imprecise results from the small number of participants in the studies or because the studies could not be combined statistically. The numbers in the brackets show the range in which the actual effect could be. Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.

WHAT DOES THE RESEARCH SAY?

There were 11 studies that tested the effects of tea on the risk of CVD after 3 to 6 months. People who were healthy or who already had a high risk of CVD were in the studies. Green tea and black tea were tested sometimes as tea and sometimes as pills that contained tea extract. The evidence from the research was moderate quality or low quality. “High quality” means something will happen, moderate quality means it probably will happen, and “low quality” means it may happen. “Very low quality” evidence means it is uncertain. The studies show that after 3 to 6 months, green or black tea may lower diastolic and systolic pressure slightly probably lowers bad cholesterol (LDL) probably has little or no effect on good cholesterol (HDL) may lower total cholesterol probably has little to no side effects None of the studies measured whether having tea would lead to fewer deaths, heart attacks, or strokes. It is also not clear what is the best amount of tea or whether drinking tea or taking tea extract in pill form is better.

WHERE DOES THIS INFORMATION COME FROM?

This summary is based on a Cochrane systematic review: Hartley L, Flowers N, Holmes J, Clarke A, Stranges S, Hooper L, Rees K. Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013 Jun 18;6:CD009934. The Cochrane Collaboration is an independent global network of people who publish Cochrane systematic reviews. Many of the people are volunteers who write reviews by pulling together scientific studies to answer healthcare questions. These reviews may answer questions about whether, for example, certain vitamins work in diabetes. The Cochrane Complementary and Alternative Medicine Field promotes Cochrane systematic reviews which cover complementary and alternative medicine in many conditions and diseases. For more information, please visit http://www.compmed.umm.edu/cochrane/.
Table

Summary of Findings

What Was MeasuredWithout TeaWith TeaQuality of the EvidenceaWhat Happens After 3-6 mo
Diastolic blood pressure(4 studies, 290 people)2 mm/Hg lowerLower by 2.8 mm/Hg more(from 1.9 to 3.8 more)b⊕⊕⊝⊝lowTea may lower diastolic blood pressure slightly
Systolic blood pressure(4 studies, 290 people)1 mm/Hg lowerLower by 2.3 mm/Hg more(from 1.1 to 3.4 more)b⊕⊕⊝⊝lowTea may lower systolic blood pressure slightly
Bad cholesterol (LDL)(8 studies, 474 people)From 0.2 lower to 0.3 mmol/L higherLower by 0.6 mmol/L more(from 0.6 to 0.4 more)b⊕⊕⊕⊝moderateTea probably lowers “bad” cholesterol (LDL)
Good cholesterol (HDL)(8 studies, 473 people)From 0.04 lower to 0.2 mmol/L higherChange of 0 mmol/L(from 0.04 more to 0.04 less)b⊕⊕⊕⊝moderateTea probably has little or no effect on “good” cholesterol (HDL)
Total cholesterol(7 studies, 446 people)Lower in 4 out of 6 studies⊕⊕⊝⊝lowTea may lower total cholesterol
Side effects(4 studies, 290 people)⊕⊕⊕⊝moderateTea probably has little or no side effects
Death, heart attack, or stroke Not measured in these studies

Details about the quality of the evidence:

Evidence was moderate quality due to the risk of bias in studies because there may not have been random sequence generation or allocation concealment.

Evidence was low quality due to risk of bias and the imprecise results from the small number of participants in the studies or because the studies could not be combined statistically.

The numbers in the brackets show the range in which the actual effect could be.

Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.

  4 in total

1.  Association of green tea consumption with risk of coronary heart disease in Chinese population.

Authors:  Jun Pang; Zheng Zhang; Tongzhang Zheng; Yue-jin Yang; Na Li; Min Bai; Yu Peng; Jin Zhang; Qiang Li; Bo Zhang
Journal:  Int J Cardiol       Date:  2014-11-11       Impact factor: 4.164

2.  A Single Oral Administration of Theaflavins Increases Energy Expenditure and the Expression of Metabolic Genes.

Authors:  Naoto Kudo; Yasunori Arai; Yoshitomo Suhara; Takeshi Ishii; Tsutomu Nakayama; Naomi Osakabe
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 3.  Synthesis of Theaflavins and Their Functions.

Authors:  Masumi Takemoto; Hiroaki Takemoto
Journal:  Molecules       Date:  2018-04-16       Impact factor: 4.411

Review 4.  The role of polyphenols in modern nutrition.

Authors:  G Williamson
Journal:  Nutr Bull       Date:  2017-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.